This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Ieo - Istituto Europeo Di Oncologia S.r.l., Ifom Fondazione Istituto Firc Di Oncologia Molecolare. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 2 
1 out of 3 Years Active: 2025
Title: Maurizio Pasi: Innovator in E3 Ligase Inhibition
Introduction
Maurizio Pasi is a notable inventor based in Torre d'Isola, Italy. He has made significant contributions to the field of molecular oncology, particularly through his innovative work on E3 ligase inhibitors.
Latest Patents
Maurizio Pasi holds a patent for "HECT E3 ligase inhibitors and uses thereof." This invention relates to tricyclic derivatives of formula (I), which are useful as inhibitors of HECT-domain-containing E3 ligases, specifically NEDD4. The patent also encompasses pharmaceutical compositions that include these compounds, their medical applications, and the processes for their preparation.
Career Highlights
Throughout his career, Maurizio Pasi has worked with esteemed organizations such as the IFOM (Fondazione Istituto Firc Di Oncologia Molecolare) and the IEO (Istituto Europeo Di Oncologia S.r.l.). His work in these institutions has been pivotal in advancing research in cancer treatment and molecular biology.
Collaborations
Maurizio has collaborated with notable colleagues, including Sebastiano Pasqualato and Raffaella Amici. These partnerships have contributed to the development of innovative solutions in the field of oncology.
Conclusion
Maurizio Pasi's contributions to the field of E3 ligase inhibition highlight his role as a significant inventor in molecular oncology. His work continues to influence the development of new therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile